Literature DB >> 22946344

Inhibition of cell proliferation and induction of apoptosis by CDDO-Me in pancreatic cancer cells is ROS-dependent.

Dorrah Deeb1, Xiaohua Gao, Yong Bo Liu, Subhash C Gautam.   

Abstract

Oleanolic acid-derived synthetic triterpenoids are broad spectrum antiproliferative and antitumorigenic agents. In this study, we investigated the role of reactive oxygen species (ROS) in induction of apoptosis and inhibition of prosurvival Akt, NF-kappaB and mTOR signaling pro-teins by methyl-2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oate (CDDO-Me) in pancreatic cancer cells. Micromolar concentrations of CDDO-Me inhibited proliferation and induced apoptosis in MiaPaCa-2 and Panc-1 pancreatic cancer cells. Treatment with CDDO-Me caused the generation of hydrogen peroxide and superoxide anion and pretreatment of cells with NADPH oxidase inhibitor diphylene iodonium (DPI) or respiratory chain complex 1 inhibitor rotenone prevented ROS generation. Pretreatment with N-acetylcysteine (NAC) or overexpression of glutathione peroxidase (GPx) or superoxide dismutase-1 (SOD-1) blocked the antiproliferative effects of CDDO-Me. Likewise, NAC prevented the induction of apoptosis (annexin V-FITC binding and cleavage of PARP-1 and procaspases-3,-8 and -9) and reversed the loss of mitochondrial membrane potential and release of cytochrome c from mitochondria by CDDO-Me. CDDO-Me down-regulated p-Akt, p-mTOR and NF-kappaB (p65) but increased the activation of Erk1/2 and NAC blocked the modulation of these cell signaling proteins by CDDO-Me. Thus, the results of this study indicate that the antiproliferative and apoptosis inducing effects of CDDO-Me are mediated through a ROS-dependent mechanism and the role of ROS in modulation of signaling proteins by CDDO-Me warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22946344      PMCID: PMC3846287     

Source DB:  PubMed          Journal:  J Exp Ther Oncol        ISSN: 1359-4117


  38 in total

1.  Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia.

Authors:  Marina Konopleva; Twee Tsao; Peter Ruvolo; Irina Stiouf; Zeev Estrov; Clinton E Leysath; Shourong Zhao; David Harris; Shirong Chang; C Ellen Jackson; Mark Munsell; Nanjoo Suh; Gordon Gribble; Tadashi Honda; W Stratford May; Michael B Sporn; Michael Andreeff
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

2.  4-Hydroxynonenal enhances MMP-2 production in vascular smooth muscle cells via mitochondrial ROS-mediated activation of the Akt/NF-kappaB signaling pathways.

Authors:  Seung J Lee; Kyo W Seo; Mi R Yun; Sun S Bae; Won S Lee; Ki W Hong; Chi D Kim
Journal:  Free Radic Biol Med       Date:  2008-09-06       Impact factor: 7.376

3.  Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages.

Authors:  N Suh; T Honda; H J Finlay; A Barchowsky; C Williams; N E Benoit; Q W Xie; C Nathan; G W Gribble; M B Sporn
Journal:  Cancer Res       Date:  1998-02-15       Impact factor: 12.701

4.  The novel triterpenoid CDDO-Me suppresses MAPK pathways and promotes p38 activation in acute myeloid leukemia cells.

Authors:  M Konopleva; R Contractor; S M Kurinna; W Chen; M Andreeff; P P Ruvolo
Journal:  Leukemia       Date:  2005-08       Impact factor: 11.528

Review 5.  Mitochondria, oxygen free radicals, and apoptosis.

Authors:  S Raha; B H Robinson
Journal:  Am J Med Genet       Date:  2001

Review 6.  The current status of combined radiotherapy and chemotherapy for locally advanced or resected pancreas cancer.

Authors:  Mary F Mulcahy; Andrew O Wahl; William Small
Journal:  J Natl Compr Canc Netw       Date:  2005-09       Impact factor: 11.908

7.  Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid.

Authors:  M T Huang; C T Ho; Z Y Wang; T Ferraro; Y R Lou; K Stauber; W Ma; C Georgiadis; J D Laskin; A H Conney
Journal:  Cancer Res       Date:  1994-02-01       Impact factor: 12.701

8.  Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole.

Authors:  Melinda S Yates; Mi-Kyoung Kwak; Patricia A Egner; John D Groopman; Sridevi Bodreddigari; Thomas R Sutter; Karen J Baumgartner; B D Roebuck; Karen T Liby; Mark M Yore; Tadashi Honda; Gordon W Gribble; Michael B Sporn; Thomas W Kensler
Journal:  Cancer Res       Date:  2006-02-15       Impact factor: 12.701

9.  The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A/J mice.

Authors:  Karen Liby; Darlene B Royce; Charlotte R Williams; Renee Risingsong; Mark M Yore; Tadashi Honda; Gordon W Gribble; Ethan Dmitrovsky; Thomas A Sporn; Michael B Sporn
Journal:  Cancer Res       Date:  2007-03-15       Impact factor: 12.701

Review 10.  Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation.

Authors:  C J Marshall
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

View more
  12 in total

1.  The role of natural products in revealing NRF2 function.

Authors:  Donna D Zhang; Eli Chapman
Journal:  Nat Prod Rep       Date:  2020-05-13       Impact factor: 13.423

2.  [6]-Gingerol inhibits de novo fatty acid synthesis and carnitine palmitoyltransferase-1 activity which triggers apoptosis in HepG2.

Authors:  Hathaichanok Impheng; Lysiane Richert; Dumrongsak Pekthong; C Norman Scholfield; Sutatip Pongcharoen; Ittipon Pungpetchara; Piyarat Srisawang
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

3.  The effect of ex vivo CDDO-Me activation on nuclear factor erythroid 2-related factor 2 pathway in white blood cells from patients with septic shock.

Authors:  Sanjeev Noel; Laura Zheng; Ana Navas-Acien; Ralph J Fuchs
Journal:  Shock       Date:  2014-11       Impact factor: 3.454

4.  Bardoxolone methyl induces apoptosis and autophagy and inhibits epithelial-to-mesenchymal transition and stemness in esophageal squamous cancer cells.

Authors:  Yan-Yang Wang; Yin-Xue Yang; Ren Zhao; Shu-Ting Pan; Hong Zhe; Zhi-Xu He; Wei Duan; Xueji Zhang; Tianxin Yang; Jia-Xuan Qiu; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2015-02-17       Impact factor: 4.162

Review 5.  Superoxide Dismutases in Pancreatic Cancer.

Authors:  Justin G Wilkes; Matthew S Alexander; Joseph J Cullen
Journal:  Antioxidants (Basel)       Date:  2017-08-19

6.  Inhibition of telomerase activity by oleanane triterpenoid CDDO-Me in pancreatic cancer cells is ROS-dependent.

Authors:  Dorrah Deeb; Xiaohua Gao; Yongbo Liu; Nadimpalli R S Varma; Ali S Arbab; Subhash C Gautam
Journal:  Molecules       Date:  2013-03-13       Impact factor: 4.411

Review 7.  Preclinical evidences toward the use of triterpenoid CDDO-Me for solid cancer prevention and treatment.

Authors:  Yan-Yang Wang; Hong Zhe; Ren Zhao
Journal:  Mol Cancer       Date:  2014-02-20       Impact factor: 27.401

8.  Ca2+ influx-mediated dilation of the endoplasmic reticulum and c-FLIPL downregulation trigger CDDO-Me-induced apoptosis in breast cancer cells.

Authors:  Soo Ah Jeong; In Young Kim; A Reum Lee; Mi Jin Yoon; Hyeseong Cho; Jong-Soo Lee; Kyeong Sook Choi
Journal:  Oncotarget       Date:  2015-08-28

Review 9.  Reactive Oxygen Species and Targeted Therapy for Pancreatic Cancer.

Authors:  Lun Zhang; Jiahui Li; Liang Zong; Xin Chen; Ke Chen; Zhengdong Jiang; Ligang Nan; Xuqi Li; Wei Li; Tao Shan; Qingyong Ma; Zhenhua Ma
Journal:  Oxid Med Cell Longev       Date:  2016-01-03       Impact factor: 6.543

10.  A recombinantly tailored β-defensin that displays intensive macropinocytosis-mediated uptake exerting potent efficacy against K-Ras mutant pancreatic cancer.

Authors:  Yue Du; Bo-Yang Shang; Wei-Jin Sheng; Sheng-Hua Zhang; Yi Li; Qing-Fang Miao; Yong-Su Zhen
Journal:  Oncotarget       Date:  2016-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.